$277 Million is the total value of Endurant Capital Management LP's 52 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 83.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $39,129,000 | +90.6% | 2,240,421 | +27.7% | 14.11% | +132.5% |
| BDX | New | BECTON DICKINSON & CO | $17,331,000 | – | 69,264 | +100.0% | 6.25% | – |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $15,139,000 | -35.6% | 244,066 | -37.4% | 5.46% | -21.5% |
| Buy | TRILLIUM THERAPEUTICS INC | $9,646,000 | +82.3% | 655,741 | +76.1% | 3.48% | +122.3% | |
| ABBV | Sell | ABBVIE INC | $9,059,000 | -48.0% | 84,544 | -57.5% | 3.27% | -36.6% |
| JNJ | Sell | JOHNSON & JOHNSON | $8,850,000 | -20.7% | 56,231 | -25.0% | 3.19% | -3.3% |
| KIDS | Buy | ORTHOPEDIATRICS CORP | $7,962,000 | +36.8% | 193,008 | +52.3% | 2.87% | +66.8% |
| ABC | New | AMERISOURCEBERGEN CORP | $7,658,000 | – | 78,339 | +100.0% | 2.76% | – |
| SIBN | Sell | SI BONE INC | $7,622,000 | -30.6% | 254,907 | -45.0% | 2.75% | -15.4% |
| SNN | New | SMITH & NEPHEW PLCspdn adr new | $7,554,000 | – | 179,138 | +100.0% | 2.72% | – |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $7,290,000 | +98.0% | 1,126,675 | -21.4% | 2.63% | +141.4% |
| ANTM | Buy | ANTHEM INC | $7,268,000 | +51.1% | 22,634 | +26.4% | 2.62% | +84.3% |
| SYNH | Sell | SYNEOS HEALTH INCcl a | $6,946,000 | +16.5% | 101,953 | -9.1% | 2.50% | +42.1% |
| MTEM | Buy | MOLECULAR TEMPLATES INC | $6,397,000 | +38.6% | 681,243 | +61.1% | 2.31% | +69.0% |
| FATE | Buy | FATE THERAPEUTICS INC | $6,055,000 | +169.5% | 66,585 | +18.5% | 2.18% | +228.9% |
| EHC | Sell | ENCOMPASS HEALTH CORP | $6,045,000 | -66.3% | 73,104 | -73.5% | 2.18% | -58.9% |
| OCUL | Sell | OCULAR THERAPEUTIX INC | $6,013,000 | -5.6% | 290,465 | -65.3% | 2.17% | +15.1% |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $5,811,000 | +26.7% | 1,078,177 | +87.7% | 2.10% | +54.6% |
| AHCO | Sell | ADAPTHEALTH CORP | $5,650,000 | -50.0% | 150,414 | -71.0% | 2.04% | -39.0% |
| AZYO | New | AZIYO BIOLOGICS INC | $5,564,000 | – | 408,213 | +100.0% | 2.01% | – |
| OMI | New | OWENS & MINOR INC NEW | $5,529,000 | – | 204,384 | +100.0% | 1.99% | – |
| AVTR | New | AVANTOR INC | $5,483,000 | – | 194,777 | +100.0% | 1.98% | – |
| ESPR | Buy | ESPERION THERAPEUTICS INC NE | $5,390,000 | +6.7% | 207,293 | +52.5% | 1.94% | +30.1% |
| CI | Sell | CIGNA CORP NEW | $5,222,000 | -54.3% | 25,085 | -62.8% | 1.88% | -44.3% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $4,838,000 | – | 28,378 | +100.0% | 1.74% | – |
| INSM | Sell | INSMED INC | $4,139,000 | -10.8% | 124,323 | -13.9% | 1.49% | +8.8% |
| LH | New | LABORATORY CORP AMER HLDGS | $4,037,000 | – | 19,834 | +100.0% | 1.46% | – |
| STRO | Sell | SUTRO BIOPHARMA INC | $3,735,000 | -19.6% | 172,047 | -62.8% | 1.35% | -2.0% |
| MBIO | Sell | MUSTANG BIO INC | $3,376,000 | -24.7% | 892,027 | -37.3% | 1.22% | -8.1% |
| GDRX | New | GOODRX HLDGS INC | $3,121,000 | – | 77,379 | +100.0% | 1.13% | – |
| HUM | New | HUMANA INC | $3,079,000 | – | 7,504 | +100.0% | 1.11% | – |
| SELB | Sell | SELECTA BIOSCIENCES INC | $3,001,000 | -20.0% | 990,563 | -34.5% | 1.08% | -2.4% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $2,844,000 | – | 56,891 | +100.0% | 1.03% | – |
| ANGO | New | ANGIODYNAMICS INC | $2,835,000 | – | 184,901 | +100.0% | 1.02% | – |
| PRAH | New | PRA HEALTH SCIENCES INC | $2,708,000 | – | 21,590 | +100.0% | 0.98% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $2,516,000 | – | 54,221 | +100.0% | 0.91% | – |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $2,362,000 | +31.2% | 133,648 | +13.8% | 0.85% | +60.2% |
| CNC | Sell | CENTENE CORP DEL | $2,300,000 | -47.0% | 38,313 | -48.5% | 0.83% | -35.4% |
| IMUX | Buy | IMMUNIC INC | $2,119,000 | +2.9% | 138,613 | +25.0% | 0.76% | +25.5% |
| ZTS | Sell | ZOETIS INCcl a | $2,100,000 | -73.0% | 12,691 | -73.0% | 0.76% | -67.0% |
| Buy | APTOSE BIOSCIENCES INC | $2,093,000 | +1.1% | 477,895 | +38.5% | 0.76% | +23.4% | |
| EUCRU | New | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $2,079,000 | – | 195,000 | +100.0% | 0.75% | – |
| PRTA | Sell | PROTHENA CORP PLC | $1,823,000 | -30.6% | 151,820 | -42.2% | 0.66% | -15.3% |
| ALBO | Sell | ALBIREO PHARMA INC | $1,586,000 | -8.9% | 42,292 | -18.9% | 0.57% | +11.1% |
| MRK | New | MERCK & CO. INC | $1,220,000 | – | 14,919 | +100.0% | 0.44% | – |
| QTNT | New | QUOTIENT LTD | $1,181,000 | – | 226,593 | +100.0% | 0.43% | – |
| PNTG | Buy | PENNANT GROUP INC | $1,058,000 | +100.4% | 18,227 | +33.1% | 0.38% | +144.9% |
| MDVL | New | MEDAVAIL HOLDINGS INC | $955,000 | – | 63,455 | +100.0% | 0.34% | – |
| SENSEONICS HLDGS INCnote 5.250% 2/0 | $638,000 | -6.5% | 1,500,000 | 0.0% | 0.23% | +13.9% | ||
| AKTX | New | AKARI THERAPEUTICS PLCsponsored adr | $382,000 | – | 206,561 | +100.0% | 0.14% | – |
| SLDB | New | SOLID BIOSCIENCES INC | $346,000 | – | 45,682 | +100.0% | 0.12% | – |
| FSTX | New | F-STAR THERAPEUTICS INC | $202,000 | – | 20,445 | +100.0% | 0.07% | – |
| CRBP | Exit | CORBUS PHARMACEUTICALS HLDGS | $0 | – | -89,886 | -100.0% | -0.05% | – |
| ALRN | Exit | AILERON THERAPEUTICS INC | $0 | – | -263,439 | -100.0% | -0.10% | – |
| ADCT | Exit | ADC THERAPEUTICS SA | $0 | – | -12,000 | -100.0% | -0.12% | – |
| INBX | Exit | INHIBRX INC | $0 | – | -35,935 | -100.0% | -0.19% | – |
| AXGN | Exit | AXOGEN INC | $0 | – | -70,209 | -100.0% | -0.24% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -12,575 | -100.0% | -0.30% | – |
| CRTX | Exit | CORTEXYME INC | $0 | – | -21,827 | -100.0% | -0.32% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -23,588 | -100.0% | -0.43% | – |
| ARCT | Exit | ARCTURUS THERAPEUTICS HLDGS | $0 | – | -34,485 | -100.0% | -0.44% | – |
| LMNX | Exit | LUMINEX CORP DEL | $0 | – | -68,131 | -100.0% | -0.53% | – |
| DVA | Exit | DAVITA INC | $0 | – | -21,002 | -100.0% | -0.53% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -421,398 | -100.0% | -0.59% | – |
| BIO | Exit | BIO RAD LABS INCcl a | $0 | – | -3,916 | -100.0% | -0.60% | – |
| ALC | Exit | ALCON AG | $0 | – | -38,373 | -100.0% | -0.65% | – |
| TBIO | Exit | TRANSLATE BIO INC | $0 | – | -176,710 | -100.0% | -0.71% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -97,374 | -100.0% | -0.72% | – |
| CALT | Exit | CALLIDITAS THERAPEUTICS ABsponsered ads | $0 | – | -111,467 | -100.0% | -0.79% | – |
| DGX | Exit | QUEST DIAGNOSTICS INC | $0 | – | -29,041 | -100.0% | -0.98% | – |
| PETS | Exit | PETMED EXPRESS INC | $0 | – | -105,895 | -100.0% | -0.99% | – |
| HAE | Exit | HAEMONETICS CORP | $0 | – | -41,607 | -100.0% | -1.07% | – |
| VAPO | Exit | VAPOTHERM INC | $0 | – | -125,675 | -100.0% | -1.08% | – |
| PDCO | Exit | PATTERSON COS INC | $0 | – | -163,415 | -100.0% | -1.16% | – |
| XBI | Exit | SPDR SER TRput | $0 | – | -52,000 | -100.0% | -1.71% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -40,419 | -100.0% | -1.78% | – |
| CNMD | Exit | CONMED CORP | $0 | – | -81,205 | -100.0% | -1.89% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -54,234 | -100.0% | -2.18% | – |
| IWM | Exit | ISHARES TRput | $0 | – | -80,500 | -100.0% | -3.57% | – |
| IART | Exit | INTEGRA LIFESCIENCES HLDGS C | $0 | – | -281,608 | -100.0% | -3.93% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -91,300 | -100.0% | -9.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
| SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.